Equine herpesvirus 1 myeloencephalopathy incidence and case fatality rates in the USA
Journal of Veterinary Internal Medicine · 01.09.2026 · 40 (5)
DOI: 10.1093/jvimsj/aalag271 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, online erschienen am 29.10.2026. Verfasst von Albert Picado und 5 weiteren Autor:innen. Beteiligte Einrichtung: Global Innovation, Boehringer Ingelheim Animal Health France, Saint-Priest, France. Hauptthemen laut MEDLINE: Herpesvirus 1, Equid, Horse Diseases, Herpesviridae Infections. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Equine herpesvirus 1 (EHV-1) myeloencephalopathy (EHM) has substantial animal welfare and economic consequences. Despite extensive research, population-level estimates of EHM incidence and case fatality rates remain poorly characterized. Hypothesis/Objectives Describe the burden of EHM and estimate EHM attack and case fatality rates in the United States. Animals None.
Methods
A retrospective observational study was conducted using surveillance data collected by the Equine Disease Communication Center (EDCC) in the United States during 2019-2023. Regression models were used to estimate the mean annual EHM incidence and to quantify attack and fatality rates. The incidence and potential seasonality of EHM by age category were also assessed.
Results
Surveillance data showed that isolated EHM cases predominated, and the estimated mean annual incidence in the United States was 6.7 per million horses (95% CI, 4.9-8.9). The attack rate was 4.3% (95% CI, 3.5-5.4) and the case fatality rate was 49.5% (95% CI, 40.5-60.5). In the United States, older horses (>19 years) had higher EHM incidence than younger horses. Cases were more frequent from January to June, peaking in March. Conclusions and clinical importance Equine herpesvirus 1 myeloencephalopathy is an uncommon clinical manifestation of EHV-1 infection, but the high case fatality rate emphasizes the clinical relevance of this condition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Global Innovation, Boehringer Ingelheim Animal Health France, Saint-Priest, France.
- Global Innovation, Boehringer Ingelheim Vetmedica GmbH, Ingelheim, Germany.
- Global Innovation, Boehringer Ingelheim Animal Health France, Saint-Vulbas, France.
- Global Strategic Marketing, Boehringer Ingelheim Vetmedica GmbH, Ingelheim, Germany.
ORCID-Profile: Albert Picado, Tobias Warnken, Jeroen Kortekaas
Zitieren
APA
Picado, A., Mundt, A., Tore, G., Diawara, A., Warnken, T., & Kortekaas, J. (2026). Equine herpesvirus 1 myeloencephalopathy incidence and case fatality rates in the USA. Journal of Veterinary Internal Medicine, 40(5). https://doi.org/10.1093/jvimsj/aalag271
Vancouver
Picado A, Mundt A, Tore G, Diawara A, Warnken T, Kortekaas J. Equine herpesvirus 1 myeloencephalopathy incidence and case fatality rates in the USA. Journal of Veterinary Internal Medicine. 2026;40(5). doi:10.1093/jvimsj/aalag271
BibTeX
@article{Picado2026,
author = {Picado, Albert and Mundt, Alice and Tore, Gessica and Diawara, Aissatou and Warnken, Tobias and Kortekaas, Jeroen},
title = {Equine herpesvirus 1 myeloencephalopathy incidence and case fatality rates in the USA},
journal = {Journal of Veterinary Internal Medicine},
year = {2026},
volume = {40},
number = {5},
doi = {10.1093/jvimsj/aalag271}
}
EUVIMED